Predictive factors of pathologic response towards trastuzumab as neoadjuvant chemotherapy in HER2-positive breast cancer patients.
Phase of Trial: Phase II
Latest Information Update: 13 Oct 2014
At a glance
- Drugs Trastuzumab (Primary) ; Antineoplastics
- Indications Advanced breast cancer; Breast cancer
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 13 Oct 2014 New trial record